Solid tumors

Calevia plans to develop a suite of MesoGraf™Xide-based bio-conjugates for the thermal eradication of a range of solid cancers, including protate, skin, bowel, head and neck and cancers of urological origin in men and women.

We believe our novel photothermal therapy has broad clinical application for:

Please click here for information about Calevia's partnering program.